Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin in IUGR with Oligohydramnios
NCT07462182Not yet recruiting
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of enoxaparin in intrauterine growth restriction (IUGR) and Oligohydramnios (Oligo) (2 arms). Primary endpoints: Live birth at 12 weeks and Low Birth weight at 12 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
enoxaparin
03
Conditions
intrauterine growth restriction (IUGR)Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT07462182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07462182.